BR100 Increased By (0.02%)
BR30 Increased By (0.06%)
KSE100 Decreased By (-0%)
KSE30 Increased By (0.05%)
BECO 5.52 Decreased By ▼ -0.02 (-0.36%)
BML 56.70 Decreased By ▼ -0.39 (-0.68%)
BOP 35.20 Decreased By ▼ -0.01 (-0.03%)
CNERGY 8.15 Decreased By ▼ -0.05 (-0.61%)
DCL 11.61 Decreased By ▼ -0.03 (-0.26%)
FCCL 56.61 Increased By ▲ 0.12 (0.21%)
FCSC 5.38 Increased By ▲ 0.06 (1.13%)
FFL 17.95 Decreased By ▼ -0.11 (-0.61%)
FNEL 1.29 No Change ▼ 0.00 (0%)
HUMNL 11.10 Decreased By ▼ -0.09 (-0.8%)
KEL 8.39 Increased By ▲ 0.19 (2.32%)
KOSM 6.63 Decreased By ▼ -0.04 (-0.6%)
MLCF 101.06 Increased By ▲ 0.30 (0.3%)
NBP 202.44 Decreased By ▼ -0.56 (-0.28%)
PACE 11.42 Decreased By ▼ -0.07 (-0.61%)
PAEL 43.32 Increased By ▲ 0.24 (0.56%)
PIAHCLA 27.24 Increased By ▲ 0.24 (0.89%)
PIBTL 17.82 Decreased By ▼ -0.02 (-0.11%)
PPL 244.79 Increased By ▲ 2.16 (0.89%)
PRL 35.71 Decreased By ▼ -0.16 (-0.45%)
PTC 65.45 Decreased By ▼ -0.40 (-0.61%)
SEARL 93.55 Decreased By ▼ -0.03 (-0.03%)
SSGC 32.98 Increased By ▲ 0.75 (2.33%)
TELE 9.04 Decreased By ▼ -0.07 (-0.77%)
THCCL 66.80 Increased By ▲ 0.31 (0.47%)
TPLP 10.85 Decreased By ▼ -0.10 (-0.91%)
TREET 25.48 Decreased By ▼ -0.24 (-0.93%)
TRG 65.90 Decreased By ▼ -0.05 (-0.08%)
WAVES 11.13 Decreased By ▼ -0.03 (-0.27%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
Topic

Pfizer Inc

Indian shares rise

Indian shares rise

Published 09 Nov, 2021 04:48am
BENGALURU: Indian shares ended higher on Monday, led by financial and energy stocks, while Pfizer Inc’s local arm...
Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion

Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion

Published 04 May, 2021 07:48pm
  • It is expected to make up for more than one-third of Pfizer's full-year sales, with the company in supply talks with several countries for 2022 and beyond.
  • "Based on what we've seen, we believe that a durable demand for our COVID-19 vaccine - similar to that of the flu vaccines - is a likely outcome," Chief Executive Albert Bourla said in his prepared remarks.
Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

Published 30 Apr, 2021 04:51pm
  • The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
  • The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
Loading...